Get the Stockscreener App
130.71
2.67%
-3.59
After Hours:
131.00
0.29
+0.22%
Dexcom Inc stock is currently priced at $130.71, with a 24-hour trading volume of 2.80M.
It has seen a -2.67% decreased in the last 24 hours and a -2.58% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $134.6 pivot point. If it approaches the $130.8 support level, significant changes may occur.
Dexcom Inc Stock (DXCM) Financials Data
Dexcom Inc (DXCM) Revenue 2024
DXCM reported a revenue (TTM) of $3.62 billion for the quarter ending December 31, 2023, a +24.49% rise year-over-year.
Dexcom Inc (DXCM) Net Income 2024
DXCM net income (TTM) was $541.50 million for the quarter ending December 31, 2023, a +58.70% increase year-over-year.
Dexcom Inc (DXCM) Cash Flow 2024
DXCM recorded a free cash flow (TTM) of $511.90 million for the quarter ending December 31, 2023, a +68.00% increase year-over-year.
Dexcom Inc (DXCM) Earnings per Share 2024
DXCM earnings per share (TTM) was $1.31 for the quarter ending December 31, 2023, a +61.73% growth year-over-year.
Dexcom Inc Stock (DXCM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SAYER KEVIN R | President CEO and Chairman |
Apr 08 '24 |
Sale |
138.30 |
49,633 |
6,864,136 |
283,893 |
| Brown Michael Jon | EVP Chief Legal Officer |
Mar 28 '24 |
Sale |
140.04 |
2,624 |
367,472 |
68,682 |
| Stern Sadie | EVP Chief Human Resources |
Mar 25 '24 |
Sale |
140.00 |
4,137 |
579,180 |
76,304 |
| Dolan Matthew Vincent | EVP Strategy & Corp Dev |
Mar 15 '24 |
Sale |
130.21 |
4,203 |
547,259 |
44,367 |
| SAYER KEVIN R | President CEO and Chairman |
Mar 12 '24 |
Sale |
133.36 |
81,007 |
10,802,803 |
333,526 |
| Stern Sadie | EVP Chief Human Resources |
Mar 12 '24 |
Sale |
133.61 |
20,321 |
2,715,006 |
80,441 |
| Leach Jacob Steven | EVP Chief Operating Officer |
Mar 12 '24 |
Sale |
134.41 |
14,639 |
1,967,638 |
273,913 |
| Sylvain Jereme M | EVP Chief Financial Officer |
Mar 12 '24 |
Sale |
134.41 |
11,661 |
1,567,363 |
85,534 |
| Brown Michael Jon | EVP Chief Legal Officer |
Mar 12 '24 |
Sale |
134.41 |
8,799 |
1,182,680 |
71,306 |
| Dolan Matthew Vincent | EVP Strategy and Corporate |
Mar 12 '24 |
Sale |
134.41 |
6,710 |
901,896 |
48,570 |
Dexcom Inc Stock (DXCM) Latest News
3 Innovative Stocks to Buy Before Earnings Amid the Market Pullback
Zacks Investment Research
Reasons to Retain DexCom (DXCM) Stock in Your Portfolio for Now
Zacks Investment Research
Zacks Industry Outlook Highlights Edwards Lifesciences, DexCom and STERIS
Zacks Investment Research
DexCom (DXCM) Stock Moves -1.16%: What You Should Know
Zacks Investment Research
3 Medical Instruments Stocks to Buy Amid Improving Industry Trends
Zacks Investment Research
DexCom (DXCM), MD Revolution Unite to Boost Diabetes Management
Zacks Investment Research
About Dexcom Inc
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers. Its products include DexCom G5 mobile continuous glucose monitoring system to communicate directly to patient's mobile device; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC to develop a series of next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
COMPANY PROFILE
NameDexcom Inc
SectorHealthcare (1205)
IndustryMedical Devices (158)
Webdexcom.com
Phone858-200-0200
Employee2,290
Twitter
@dexcom
SEC filings
Latest SEC Filings
Next earning date2024-04-25
Address6340 Sequence Drive, San Diego, CA, United States (92121)
0.59%
0.08%
Cap:
|
Volume (24h):